Natus Medical, Inc. (BABY) Reports In-Line Q2 EPS; Boosts FY12 Outlook; Guides Q3, Q4
Tweet Send to a Friend
Natus Medical, Inc. (NASDAQ: BABY) reported Q2 EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
